gracecastuc107_lung_dr. kelly on repeat biopsy molecular testing
Published 11 years ago • 26 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:44
gracecastuc115_lung_dr. kelly on repeat biopsy with acquired resistance targeted therapy
-
2:11
gracecastuc-027_lung_dr. kelly - what molecular markers to send in for adv. nsclc patients?
-
2:44
gracecastuc087_lung_dr. kelly on targeted therapy
-
3:56
preferential timing for molecular testing in nsclc
-
2:23
gracecastuc-077_lung_dr. kelly on "my approach to maintenance therapy for advanced nsclc"
-
1:09
gracecastuc-037_lung_repeat biopsy at initial diag. or with acqd. resistance to a targeted therapy?
-
1:10
gracecastuc-070_lung_dr. reckamp on "which patients do you test for molecular marker, and for what?"
-
35:02
gracecast-039_lung-cancer_pennell nsclc molecular markers webinar
-
24:30
gracecast-100_lung-cancer_mm in lc pt 5: dr. spigel on incorporating targets into clinical trials
-
1:35
gracecastuc 122 lung_dr. goldberg on which patients to seek molecular testing
-
3:32
gracecastuc100_lung_drs. camidge and langer on which patients send molecular marker testing
-
3:10
gracecastuc-062_lung_dr. spigel: we've probably made maint. therapy more complicated than necessary
-
25:07
gracecast-101_lung-cancer_mm in lc pt6: dr. goss on incorporating markers across a hc system
-
1:36
gracecastuc-073_lung_will new forms of mutation testing be available beyond major research centers?
-
3:22
discussing biomarkers and pd-l1 testing with your doctor - lung cancer onctalk 2022
-
17:28
gracecast-098_lung-cancer_mm in lc pt 3: who to test and what to test for -- panel discussion
-
0:49
gracecastuc081_lung_which patients send for molecular testing
-
6:11
gracecastuc-012_lung_the more you seek, the more you find
-
1:14
gracecastuc 119 lung_dr. wakelee on targeted therapies generalizable to wider range of lung cancers